🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Protara Therapeutics, Inc.

Protara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

N/A

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

No tags available.

Symbol: TARA

Recent Price: $5.28

Industry: Biotechnology

CEO: Mr. Jesse Shefferman

Sector: Healthcare

Employees: 26

Address: 345 Park Avenue South, New York, NY 10010

Phone: 646 844 0337

Last updated: 2024-12-31